Results 11 to 20 of about 229,451 (392)

Identification of the α2 chain of interleukin‐13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient‐derived xenograft models

open access: yesCancer Reports, 2023
Background Several treatment strategies use upfront chemotherapy or androgen receptor axis‐targeting therapies for metastatic prostate cancer. However, there are no useful biomarkers for selecting appropriate patients who urgently require these ...
Takahiro Nagai   +15 more
doaj   +1 more source

Testosterone Metabolite 6β‐Hydroxytestosterone Contributes to Angiotensin II‐Induced Abdominal Aortic Aneurysms in Apoe–/– Male Mice

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Sex is a prominent risk factor for abdominal aortic aneurysms (AAAs), and angiotensin II (Ang II) induces AAA formation to a greater degree in male than in female mice.
Kamalika Mukherjee   +6 more
doaj   +1 more source

Oral ethinylestradiol in castration resistent prostate cancer: 10 year experience [PDF]

open access: yes, 2015
To describe our 10-year experience with the use of oral ethinylestradiol in the treatment of metastatic castration-resistant prostate cancer. METHODS: From February 2000 to April 2010, 116 patients with a metastatic castration-resistant prostate cancer
Aggarwal   +16 more
core   +1 more source

Measurement of Fecal Testosterone Metabolites in Mice: Replacement of Invasive Techniques [PDF]

open access: yes, 2020
Testosterone is the main reproductive hormone in male vertebrates and conventional methods to measure testosterone rely on invasive blood sampling procedures.
Auer, Kerstin E.   +5 more
core   +1 more source

Optimal Methods of Documenting Analgesic Efficacy in Neonatal Piglets Undergoing Castration

open access: yesAnimals, 2020
Analgesic products for piglet castration are critically needed. This requires extensive animal experimentation such as to meet regulatory-required proof of efficacy. At present, there are no validated methods of assessing pain in neonatal piglets.
Meredith Sheil, Adam Polkinghorne
doaj   +1 more source

A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer. [PDF]

open access: yes, 2017
Lessons learnedThe combination of standard dose abiraterone acetate and BEZ235, a pan-class I PI3K and mTORC1/2 inhibitor, was poorly tolerated in men with progressive mCRPC.Although the clinical development of BEZ235 has been discontinued in prostate ...
Friedlander, Terence   +6 more
core   +1 more source

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND We previously reported that olaparib led to significantly longer imaging-based progression-free survival than the physician's choice of enzalutamide or abiraterone among men with metastatic castration-resistant prostate cancer who had ...
M. Hussain   +19 more
semanticscholar   +1 more source

Responsible ownership for cats and dogs from different urban neighborhoods of the City of Umuarama, Paraná, Brazill

open access: yesBrazilian Journal of Veterinary Medicine, 2020
The article analyzed the responsible care and well-being of dogs and cats of different districts of the municipality of Umuarama, PR. We interviewed 53 tutors by means of a directed questionnaire, obtaining 106 animals evaluated indirectly.
Thaís Camaso de Sá   +8 more
doaj   +1 more source

Sugarcane bagasse or elephant grass hay in diets for goats: Performance, feeding behavior and carcass characteristics

open access: yesRevista Colombiana de Ciencias Pecuarias, 2021
Background: Novel feeding strategies should be developed to produce high-quality meat in current goat production systems. Objective: To evaluate the effects of castration and the association of spineless cactus with sugarcane bagasse or elephant grass ...
Victor H. Campelo-Lima   +7 more
doaj   +1 more source

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma. [PDF]

open access: yes, 2016
Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer death among men in the United States. In recent years, several new agents, including cancer immunotherapies, have been approved or are currently being ...
Bander, Neil H   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy